BioSpace News Archive

Optibrium, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery

Alliance for medicinal chemistry optimization and development of novel checkpoint blockade approach

Cynata Therapeutics Limited is pleased to announce data from a preclinical model demonstrating that its proprietary Cymerus™ mesenchymal stem cells (MSCs) significantly ameliorate the effects of cytokine release syndrome (CRS), a potentially severe and life-threatening adverse reaction to cancer immunotherapy.

Carestream Health has started shipping a new version of software for its CARESTREAM OnSight 3D Extremity System (see video link) that offers new standard features as well as optional enhanced metal artifact reduction software that can improve visibility of anatomy around metallic objects.

Combined Company expected to drive growth and shareholder value with North America’s largest sales force, broadest product offering, and most efficient supply chain network in the industry

Neurimmune today announced the achievement of a key preclinical milestone in the ongoing collaboration with Ono Pharmaceutical Co., Ltd. In November 2017, the parties entered into a collaboration focused on the development of human-derived antibodies against a novel therapeutic target for neurodegenerative diseases.

Galapagos NV announces a share capital increase as a result of a public offering of American Depositary Shares.

Independent Study Data Shows Noninvasive Test Could Eliminate the Biopsy Needle, Lower Patient Anxiety and Costs

Peerwith is pleased to announce a new partnership with the independent academic publisher, De Gruyter, a company with a tradition dating back to 1749.

Investment in digital healthcare company Rinicare is milestone deal for Fund